High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population
Status:
Completed
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
A phase 4 prospective, randomized, open-label clinical trial evaluating the efficacy of high
dose dual therapy vs standard triple therapy in a diverse, urban New York City population.